EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges

Sumit Ghosh iD, Alex M Brown, Chris Jenkins, Katie Campbell

Applied Biosafety · 01.03.2020 · 25 (1) · 7-18

DOI: 10.1177/1535676019899502 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Applied Biosafety, erschienen am 01.03.2020. Verfasst von Sumit Ghosh und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA. Die Arbeit wurde bisher 219-mal zitiert (Crossref) und nennt 129 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

National Institutes of Health (NIH) defines gene therapy as an experimental technique that uses genes to treat or prevent disease. Although gene therapy is a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections), the technique remains risky and is still under study to make sure that it will be effective and safe.

Methods

Applications of viral vectors and nonviral gene delivery systems have found an encouraging new beginning in gene therapy in recent years. Although several viral vectors and nonviral gene delivery systems have been developed in the past 3 decades, no one delivery system can be applied in gene therapy to all cell types in vitro and in vivo. Furthermore, the use of viral vector systems (both in vitro and in vivo) present unique occupational health and safety challenges. In this review article, we discuss the biosafety challenges and the current framework of risk assessment for working with the viral vector systems.

Discussion

The recent advances in the field of gene therapy is exciting, but it is important for scientists, institutional biosafety committees, and biosafety officers to safeguard public trust in the use of this technology in clinical trials and make conscious efforts to engage the public through ongoing forums and discussions.

Schlagwörter

Stichwörter der Autor:innen

biosafetygene therapyoccupational healthrisk assessmentviral vectors

Autor:innen und Institutionen

  • The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.
  • Clinical Biosafety Services, A Division of Sabai Global, Wildwood, MO, USA.

ORCID-Profile: Sumit Ghosh

Zitieren

APA

Ghosh, S., Brown, A. M., Jenkins, C., & Campbell, K. (2020). Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges. Applied Biosafety, 25(1), 7-18. https://doi.org/10.1177/1535676019899502

Vancouver

Ghosh S, Brown AM, Jenkins C, Campbell K. Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges. Applied Biosafety. 2020;25(1):7-18. doi:10.1177/1535676019899502

BibTeX
@article{Ghosh2020,
  author = {Ghosh, Sumit and Brown, Alex M and Jenkins, Chris and Campbell, Katie},
  title = {Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges},
  journal = {Applied Biosafety},
  year = {2020},
  volume = {25},
  number = {1},
  pages = {7--18},
  doi = {10.1177/1535676019899502}
}
Kostenlos starten →